Leuco-methylthioninium bis(Hydromethanesulfonate)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Leuco-methylthioninium bis(Hydromethanesulfonate), covering 2020-06-02 to 2020-06-02. Get the full timeline:
Most recent: Clinical Trial Update: Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD) [Phase 3]